Latin American consensus on tapering of biological therapy in psoriasis

Angela María Londoño-García*, Juan Raúl Castro-Ayarza, Manuel Darío Franco Franco, Cesar Fernando González Ardila, Gabriel Magariños, Enrique Salvador Rivas Zaldívar, Susan Martínez, Linda Ibatá, Julieth Carolina Castillo, Paola Jimena Cárdenas Rojas, Evelyn Giuliana Castro Vargas, Claudia Romina Contreras, Claudia de la Cruz Fernández, Andrés Chavarriaga Restrepo, Cristina Mariela Echeverria, André Vicente Esteves de Carvalho, Benjamín Hidalgo Matlock, Enrique Loayza, Matías Rafael Maskin, Ricardo RomitiFernando Valenzuela

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

Background: Biologic therapy is an effective psoriasis treatment. However, its long-term use carries the risk of serious adverse effects and high costs for the healthcare system, which is particularly relevant in resource-limited Latin American countries. Therefore, there is scientific interest in exploring the feasibility of tapering therapy in low disease activity or clinical remission. Objective: To provide expert consensus-based recommendations to guide personalized and efficient tapering of biologic agents in adult patients with cutaneous psoriasis. Methods: Following an exhaustive systematic literature review, a consensus was developed using a modified Delphi methodology by a group of Latin American clinical dermatologists and an independent methodological team. The topics covered include treatment goals, tapering objectives and strategies, regimens, monitoring and tapering failure, and implementation considerations in patients with psoriasis treated with biological agents. Results: The expert panel reached a consensus on five general principles and 13 recommendations for tapering biological therapy for psoriasis. These recommendations provide scientific support for dermatologists and healthcare providers regarding criteria for tapering, strategies and regimens, monitoring, failure management, and considerations for implementation. Conclusion: Tapering of biologics appears to be effective and safe in psoriasis patients with low stable activity or clinical remission. This Latin American consensus was developed in recognition of the need for rational and optimal use of biologics, while individualizing cases to apply best clinical practices.

Original languageEnglish
Article number501134
JournalAnais Brasileiros de Dermatologia
Volume100
Issue number4
DOIs
StatePublished - 1 Jul 2025

Bibliographical note

Publisher Copyright:
© 2025 Sociedade Brasileira de Dermatologia

Keywords

  • Biological therapy
  • Consensus
  • Delphi technique
  • Drug tapering
  • Latin America
  • Psoriasis

Fingerprint

Dive into the research topics of 'Latin American consensus on tapering of biological therapy in psoriasis'. Together they form a unique fingerprint.

Cite this